Latest News about VRTX
Recent news which mentions VRTX
3 Biotech Stocks That Are Too Cheap to Ignore
December 19, 2021
From Motley Fool
5 Unstoppable Trends to Invest $5,000 In for 2022
December 19, 2021
From Motley Fool
3 Biotech Stocks That Could Make You Richer in December (and Beyond)
December 12, 2021
From Motley Fool
Could Vertex Have a Cure for Type 1 Diabetes on the Way?
December 11, 2021
Tickers
VRTX
From Motley Fool
Got $1,000? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond
December 10, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
3 Beaten-Down Biotech Stocks -- Are They Bargains Now?
December 08, 2021
From Motley Fool
Got $10,000? 5 Unstoppable Stocks to Buy to End the Year Right
December 05, 2021
From Motley Fool
Is Vertex Pharmaceuticals Stock a Buy Now?
December 04, 2021
From Motley Fool
Got $1,000? Check Out These 3 Top Biotech Stocks
December 03, 2021
From Motley Fool
What 6 Analyst Ratings Have To Say About Vertex Pharmaceuticals
December 02, 2021
Tickers
VRTX
From Benzinga
From Motley Fool
Why Are Vertex Pharmaceuticals Shares Trading Higher Today?
December 01, 2021
Tickers
VRTX
From Benzinga
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
From InvestorPlace
Will This Beaten-Down Stock Bounce Back? 3 Things to Know
November 29, 2021
From Motley Fool
7 Stocks 'On Sale' This Holiday Season
November 26, 2021
From Benzinga
Better Buy: Vertex Pharmaceuticals vs. CRISPR
November 20, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
From Benzinga
2 Beaten-Down Growth Stocks You Can Buy Right Now
November 17, 2021
From Motley Fool
From Benzinga
Being First Is Not Enough For Crispr Therapeutics
November 15, 2021
From InvestorPlace
The Key Behind Vertex's Great Q3 Results
November 11, 2021
From Motley Fool
3 Stocks Than Can Turn $10,000 Into $50,000 by 2025
November 11, 2021
From Motley Fool
Can Vertex Make Billions With a New Game-Changing Treatment? The Answer May Be Just Ahead
November 05, 2021
From Motley Fool
Why Vertex Is Striking Another Gene-Editing Deal With a Company Not Named CRISPR Therapeutics
November 04, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy in November
November 04, 2021
From Motley Fool
Could Moderna's mRNA Magic Revive Its Beaten-Down Biotech Partner?
November 04, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.